Association of resistin with metabolic syndrome in Indian subjects

Metabolic Syndrome and Related Disorders

Volumn 10, Issue 4, 2012, Pages 286-291

  Singh, Arun K ^a   Tiwari, Sunita ^a   Gupta, Abhishek ^a   Natu, Sunil M ^a   Mittal, Balraj ^b   Pant, Aditya B ^c  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^c IITR   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; RESISTIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HUMAN; INDIA; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANTHROPOMETRY; BIOLOGICAL MARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; HUMANS; INDIA; INSULIN RESISTANCE; LIPOPROTEINS, VLDL; MALE; METABOLIC SYNDROME X; PHENOTYPE; REGRESSION ANALYSIS; RESISTIN; TRIGLYCERIDES;

EID: 84864194286     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2011.0128     Document Type: Article

References (47)

1. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-312. (Pubitemid 32151228)
2. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002;1:18-23. (Pubitemid 36734011)
3. Kawashima J, Tsuruzoe K, Motoshima H, et al. Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes. Diabetologia 2003;2:231-240. (Pubitemid 36343887)
4. Shojima N, Sakoda H, Ogihara T, et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002;6:1737-1744. (Pubitemid 34564285)
5. Juan CC, Au LC, Fang VS, et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001;289:1328-1333. (Pubitemid 34076338)
6. Le Lay S, Boucher J, Rey A, et al. Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem Biophys Res Commun 2001;289:564-567. (Pubitemid 33141092)
7. Way JM, Gorgun CZ, Tong Q, et al. Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferators activated receptor gamma agonists. J Biol Chem 2001;276:25651-25653.
8. Ukkola O. Resistin-a mediator of obesity-associated insulin resistance or an innocent bystander? Eur J Endocrinol 2002; 147:571-574.
9. Palanivel R, Maida A, Liu Y, et al. Regulation of insulin signaling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin. Diabetologia 2006;1:183-190. (Pubitemid 43151630)
10. Kim KH, Lee K, Moon YS, et al. A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation. J Biol Chem 2001;14:11252-11256. (Pubitemid 38089312)
11. Sheng CH, Di J, Jin Y, et al. Resistin is expressed in human hepatocytes and induces insulin resistance. Endocrine 2008; 33:135-143.
12. Holcomb IN, Kabakoff RC, Chan B, et al. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 2000; 15:4046-4055. (Pubitemid 30608543)
13. Reilly MP, Lehrke M, Wolfe ML, et al. Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 2005;7:932-939. (Pubitemid 40279897)
14. Bo S, Gambino R, Pagani A, Guidi S, Gentile L, Cassader M, Pagano GF (2005). Relationships between human plasma resistin, inflammatory markers, insulin resistance. Int J Obes 11: 1315-1320. (Pubitemid 41679262)
15. Shetty GK, Economides PA, Horton ES, et al. Circulating adiponectin, resistin levels in relation to metabolic factors, inflammatory markers, vascular reactivity in diabetic patients, subjects at risk for diabetes. Diabetes Care 2004;10: 2450-2457. (Pubitemid 39281400)
16. Filippidis G, Liakopoulos V, Mertens PR, et al. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif 2005;6: 421-428. (Pubitemid 41816068)
17. Aquilante CL, Kosmiski LA, Knutsen SD, et al. Relationship between plasma resistin concentrations, inflammatory chemokines, components of the metabolic syndrome in adults. Metab Clin Exp 2008;4:494-501. (Pubitemid 351317963)
18. Wasim H, Al-Daghri NM, Chetty R, et al. Relationship of serum adiponectin and resistin to glucose intolerance and fat topography in South-Asians. Cardiovasc Diabetol 2006; 2:5-10.
19. Burnett MS, Devaney JM, Adenika RJ, Lindsay R, Howard BV (2006). Cross-sectional associations of resistin, coronary heart disease, and insulin resistance. J Clin Endocrinol Metab 1: 64-68. (Pubitemid 43069119)
20. Degawa-Yamauchi M, Bovenkerk JE, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003;11:5452-5455. (Pubitemid 37452753)
21. Heilbronn LK, Rood J, Janderova L, et al. Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J Clin Endocrinol Metab 2004;4:1844-1848. (Pubitemid 38507943)
22. Malo E, Ukkola O, Jokela M, et al. Resistin is an indicator of the metabolic syndrome according to five different definitions in the Finnish Health 2000 survey. Metab Syndr Relat Disord 2011;9:203-210.
23. Pagano C, Marin O, Calcagno A, et al. Increased plasma resistin in adults with prader-willi syndrome is related to obesity and not to insulin resistance. J Clin Endocrinol Metab 2005;90:4335-4340. (Pubitemid 41058216)
24. Matsuda M, Kawasaki F, Yamada K, et al. Impact of adiposity and plasma adipocytokines on diabetic angiopathies in Japanese type 2 diabetic subjects. Diabet Med 2004;21:881-888. (Pubitemid 39037002)
25. Farvid MS, Ng TW, Chan DC, et al. Association of adiponectin and resistin with adipose tissue compartments, insulin resistance and dyslipidemia. Diabetes Obes Metab 2005;7: 406-413. (Pubitemid 40916583)
26. Utzschneider KM, Carr DB, Tong J, et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005;48:2330-2333. (Pubitemid 41618925)
27. Filippidis G, Liakopoulos V, Mertens PR, et al. Resistin serum levels are increased but not correlated with insulin resistance in chronic hemodialysis patients. Blood Purif 2005;23:421-428. (Pubitemid 41816068)
28. Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-2716. (Pubitemid 35403784)
29. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
30. Keskin M, Kurtoglu S, Kendirci M, et al. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:e500-e503.
31. Rajala MW, Obici S, Scherer PE, et al. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003;111:225-230. (Pubitemid 36105921)
32. Rajala MW, Scherer PE. Minireview: The adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 2003;144:3765-3773. (Pubitemid 37088727)
33. Azuma K, Katsukawa F, Oguchi S, et al. Correlation between serum resistin level and adiposity in obese individuals. Obes Res 2003;11:997-1001. (Pubitemid 41137512)
34. Silha JV, Krsek M, Skrha JV, et al. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur J Endocrinol 2003;149:331-335. (Pubitemid 37304704)
35. Pfutzner A, Langenfeld M, Kunt T, et al. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin Lab 2003;49:571-576. (Pubitemid 37493455)
36. Iqbal N, Seshadri P, Stern L, et al. Serum resistin is not associated with obesity or insulin resistance in humans. Eur Rev Med Pharmacol Sci 2005;9:161-165. (Pubitemid 40975765)
37. Cho YM, Youn B-S, Chung SS, et al. Common genetic polymorphisms in the promoter of resistin gene are major determinants of plasma resistin concentrations in humans. Diabetologia 2004;47:559-565. (Pubitemid 38491255)
38. Fujinami A, Obayashi H, Ohta K, et al. Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin Chim Acta 2004;339:57-63. (Pubitemid 37542458)
39. Lee JH, Chan JL, Yiannakouris N, et al. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: Cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. l Clin Endocrinol Metab 2003;88:4848-4856. (Pubitemid 37357535)
40. Youn B-S, Yu K-Y, Park HJ, et al. Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. Clin Endocrinol Metab 2004;89:150-156. (Pubitemid 38183874)
41. Chen CC, Li TC, Li CI, et al. Serum resistin level among healthy subjects: Relationship to anthropometric and metabolic parameters. Metabolism 2005;54:471-475.
42. Shetty GK, Economides PA, Horton ES, et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 2004;27:2450-2457. (Pubitemid 39281400)
43. Asano H, Izawa H, Nagata K, et al. Yokota. Plasma resistin concentration determined by common variants in the resistin gene and associated with metabolic traits in an aged Japanese population. Diabetologia DOI 10.1007/s00125-009- 1517-2.
44. Osawa H, Tabara Y, Kawamoto R, et al. Plasma resistin, associated with single nucleotide polymorphism - 420, is correlated with insulin resistance, lower HDL cholesterol, and high-sensitivity C-reactive protein in the Japanese general population. Diabetes Care 2007;30:1501-1506. (Pubitemid 46871161)
45. Furuhashi M, Ura N, Higashiura K, et al. Circulating resistin levels in essential hypertension. Clin Endocrinol 2003;59: 507-510. (Pubitemid 37188183)
46. Norata GD, Ongari M, Garlaschelli K, et al. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007;156:279-284. (Pubitemid 46554524)
47. Menzaghi C, Coco A, Salvemini L, et al. Heritability of serum resistin and its genetic correlation with insulin resistancerelated features in nondiabetic Caucasians. J Clin Endocrinol Metab 2006;7:2792-2795. (Pubitemid 44024653)